Suppr超能文献

混合部位脑出血/微出血:潜在的微血管病和复发风险。

Mixed-location cerebral hemorrhage/microbleeds: Underlying microangiopathy and recurrence risk.

机构信息

From the Hemorrhagic Stroke Research Program (M.P., A.C., G.B., E.A., A.A., K.M.S., A.V., S.M.G., M.E.G.), Department of Neurology, Massachusetts General Hospital Stroke Research Center, Harvard Medical School, Boston; NEUROFARBA Department (M.P., L.P.), Neuroscience Section, University of Florence, Italy; Université Paris-Descartes (G.B.), INSERM UMR 894, Department of Neuroradiology, Centre Hospitalier Sainte-Anne, France; and Division of Neurocritical Care and Emergency Neurology (J.N.G., J.R.), Massachusetts General Hospital, Harvard Medical School, Boston.

出版信息

Neurology. 2018 Jan 9;90(2):e119-e126. doi: 10.1212/WNL.0000000000004797. Epub 2017 Dec 15.

Abstract

OBJECTIVE

To assess the predominant type of cerebral small vessel disease (SVD) and recurrence risk in patients who present with a combination of lobar and deep intracerebral hemorrhage (ICH)/microbleed locations (mixed ICH).

METHODS

Of 391 consecutive patients with primary ICH enrolled in a prospective registry, 75 (19%) had mixed ICH. Their demographics, clinical/laboratory features, and SVD neuroimaging markers were compared to those of 191 patients with probable cerebral amyloid angiopathy (CAA-ICH) and 125 with hypertensive strictly deep microbleeds and ICH (HTN-ICH). ICH recurrence and case fatality were also analyzed.

RESULTS

Patients with mixed ICH showed a higher burden of vascular risk factors reflected by a higher rate of left ventricular hypertrophy, higher creatinine values, and more lacunes and severe basal ganglia (BG) enlarged perivascular spaces (EPVS) than patients with CAA-ICH (all < 0.05). In multivariable models mixed ICH diagnosis was associated with higher creatinine levels (odds ratio [OR] 2.5, 95% confidence interval [CI] 1.2-5.0, = 0.010), more lacunes (OR 3.4, 95% CI 1.7-6.8), and more severe BG EPVS (OR 5.8, 95% CI 1.7-19.7) than patients with CAA-ICH. Conversely, when patients with mixed ICH were compared to patients with HTN-ICH, they were independently associated with older age (OR 1.03, 95% CI 1.02-1.1), more lacunes (OR 2.4, 95% CI 1.1-5.3), and higher microbleed count (OR 1.6, 95% CI 1.3-2.0). Among 90-day survivors, adjusted case fatality rates were similar for all 3 categories. Annual risk of ICH recurrence was 5.1% for mixed ICH, higher than for HTN-ICH but lower than for CAA-ICH (1.6% and 10.4%, respectively).

CONCLUSIONS

Mixed ICH, commonly seen on MRI obtained during etiologic workup, appears to be driven mostly by vascular risk factors similar to HTN-ICH but demonstrates more severe parenchymal damage and higher ICH recurrence risk.

摘要

目的

评估同时出现脑叶和深部脑内出血(ICH)/微出血部位(混合 ICH)的患者中主要的脑小血管疾病(SVD)类型和复发风险。

方法

在一项前瞻性登记研究中,纳入了 391 例原发性 ICH 患者,其中 75 例(19%)为混合 ICH。将这些患者的人口统计学、临床/实验室特征和 SVD 神经影像学标志物与 191 例可能由脑淀粉样血管病(CAA-ICH)引起的患者和 125 例由单纯高血压性深部微出血和 ICH(HTN-ICH)引起的患者进行比较。还分析了 ICH 复发和病死率。

结果

与 CAA-ICH 患者相比,混合 ICH 患者的血管危险因素负担更高,左心室肥厚、肌酐值更高、腔隙和严重基底节(BG)扩大血管周围间隙(EPVS)更多(均<0.05)。多变量模型分析显示,混合 ICH 诊断与更高的肌酐水平(比值比 [OR] 2.5,95%置信区间 [CI] 1.2-5.0, = 0.010)、更多的腔隙(OR 3.4,95% CI 1.7-6.8)和更严重的 BG EPVS(OR 5.8,95% CI 1.7-19.7)相关。相比之下,当混合 ICH 患者与 HTN-ICH 患者进行比较时,与混合 ICH 相关的因素为年龄更大(OR 1.03,95% CI 1.02-1.1)、更多腔隙(OR 2.4,95% CI 1.1-5.3)和更高的微出血计数(OR 1.6,95% CI 1.3-2.0)。在 90 天幸存者中,所有 3 个类别调整后的病死率相似。混合 ICH 的 ICH 复发年发生率为 5.1%,高于 HTN-ICH,但低于 CAA-ICH(分别为 1.6%和 10.4%)。

结论

在病因学检查中常见于 MRI 的混合 ICH 似乎主要由与 HTN-ICH 相似的血管危险因素引起,但表现出更严重的实质损伤和更高的 ICH 复发风险。

相似文献

1
Mixed-location cerebral hemorrhage/microbleeds: Underlying microangiopathy and recurrence risk.
Neurology. 2018 Jan 9;90(2):e119-e126. doi: 10.1212/WNL.0000000000004797. Epub 2017 Dec 15.
3
Distribution of lacunes in cerebral amyloid angiopathy and hypertensive small vessel disease.
Neurology. 2017 Jun 6;88(23):2162-2168. doi: 10.1212/WNL.0000000000004007. Epub 2017 May 5.
5
MRI-visible perivascular spaces in cerebral amyloid angiopathy and hypertensive arteriopathy.
Neurology. 2017 Mar 21;88(12):1157-1164. doi: 10.1212/WNL.0000000000003746. Epub 2017 Feb 22.
6
Microangiopathy underlying mixed-location intracerebral hemorrhages/microbleeds: A PiB-PET study.
Neurology. 2019 Feb 19;92(8):e774-e781. doi: 10.1212/WNL.0000000000006953. Epub 2019 Jan 23.
7
Cerebral small vessel disease in patients with spontaneous cerebellar hemorrhage.
J Neurol. 2019 Mar;266(3):625-630. doi: 10.1007/s00415-018-09177-w. Epub 2019 Jan 8.
9
Enlarged perivascular spaces and florbetapir uptake in patients with intracerebral hemorrhage.
Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2339-2347. doi: 10.1007/s00259-019-04441-1. Epub 2019 Jul 29.
10
Centrum Semiovale Perivascular Space and Amyloid Deposition in Spontaneous Intracerebral Hemorrhage.
Stroke. 2021 Jul;52(7):2356-2362. doi: 10.1161/STROKEAHA.120.032139. Epub 2021 Apr 20.

引用本文的文献

1
Relationship between cerebral small vessel disease and proteinopathies in the medial temporal lobe.
Acta Neuropathol Commun. 2025 Jul 16;13(1):156. doi: 10.1186/s40478-025-02076-y.
5
Cerebral small vessel disease among rural-dwelling Chinese older adults: prevalence, distribution, and associated factors.
Brain Commun. 2025 Apr 4;7(2):fcaf136. doi: 10.1093/braincomms/fcaf136. eCollection 2025.
9
Characterizing the underlying microangiopathy of deep cerebellar intracerebral hemorrhage.
J Neurol. 2025 Jan 24;272(2):167. doi: 10.1007/s00415-025-12905-8.
10
Updated imaging markers in cerebral amyloid angiopathy: What radiologists need to know.
Jpn J Radiol. 2025 May;43(5):736-751. doi: 10.1007/s11604-024-01720-2. Epub 2024 Dec 28.

本文引用的文献

1
Distribution of lacunes in cerebral amyloid angiopathy and hypertensive small vessel disease.
Neurology. 2017 Jun 6;88(23):2162-2168. doi: 10.1212/WNL.0000000000004007. Epub 2017 May 5.
2
MRI-visible perivascular spaces in cerebral amyloid angiopathy and hypertensive arteriopathy.
Neurology. 2017 Mar 21;88(12):1157-1164. doi: 10.1212/WNL.0000000000003746. Epub 2017 Feb 22.
3
Synergistic effects of longitudinal amyloid and vascular changes on lobar microbleeds.
Neurology. 2016 Oct 11;87(15):1575-1582. doi: 10.1212/WNL.0000000000003220. Epub 2016 Sep 14.
4
Florbetapir-PET to diagnose cerebral amyloid angiopathy: A prospective study.
Neurology. 2016 Nov 8;87(19):2043-2049. doi: 10.1212/WNL.0000000000003197. Epub 2016 Sep 7.
5
Intracranial Hemorrhage Risk in the Era of Antithrombotic Therapies for Ischemic Stroke.
Curr Treat Options Cardiovasc Med. 2016 May;18(5):29. doi: 10.1007/s11936-016-0453-y.
6
Molecular Neuroimaging in Vascular Cognitive Impairment.
Stroke. 2016 Apr;47(4):1146-52. doi: 10.1161/STROKEAHA.115.007958. Epub 2016 Feb 16.
7
White matter hyperintensity patterns in cerebral amyloid angiopathy and hypertensive arteriopathy.
Neurology. 2016 Feb 9;86(6):505-11. doi: 10.1212/WNL.0000000000002362. Epub 2016 Jan 8.
9
Statins in Intracerebral Hemorrhage.
Curr Atheroscler Rep. 2015 Aug;17(8):46. doi: 10.1007/s11883-015-0526-5.
10
Incidence of symptomatic hemorrhage in patients with lobar microbleeds.
Stroke. 2014 Aug;45(8):2280-5. doi: 10.1161/STROKEAHA.114.005151. Epub 2014 Jun 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验